Recent advances in vaccines for leishmaniasis

Expert Opinion on Biological Therapy
J M RequenaM Soto

Abstract

The observation that recovery from infection with Leishmania confers immunity to reinfection suggests that control of leishmaniasis by vaccination may be possible. However, there are no vaccines available at present to control any form of leishmaniasis, despite considerable efforts. Studies of the immunopathogenesis and mechanisms of protective immunity, mainly derived from animal models of experimental leishmaniasis, have defined a number of features that should be met by an effective vaccine. In addition, several antigens have been identified that may be potential vaccine candidates, and molecular biological techniques have made them available as recombinant proteins for second-generation vaccines. Furthermore, molecules present in the saliva of Leishmania-transmitting vectors have been demonstrated as valuable candidates for the development of anti-Leishmania vaccines. This review concentrates on the most promising vaccine candidates and highlights new approaches for the development of vaccines. Finally, based on present knowledge, the future prospects for developing an effective vaccine against the different clinical forms of leishmaniasis are discussed.

References

Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·R G TitusS M Beverley
Dec 1, 1994·Vaccine·D Xu, F Y Liew
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·N D ConnellD G Russell
Aug 1, 1993·Infection and Immunity·D McMahon-PrattN H Ruddle
Apr 1, 1996·The Journal of Experimental Medicine·S StengerC Bogdan
Aug 1, 1996·The American Journal of Tropical Medicine and Hygiene·C Dye
Apr 1, 1997·Clinical Microbiology Reviews·J AlvarJ Moreno
Mar 5, 1999·Immunology Letters·A KharazmiM Kemp
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·P S WalkerJ C Vogel
Oct 8, 1999·Lancet·B L Herwaldt
Dec 22, 1999·Advances in Immunology·W Solbach, T Laskay
Jan 13, 2000·Experimental Parasitology·J A StreitM E Wilson
May 29, 2000·Vaccine·E HandmanA Sjölander
Jun 3, 2000·Annual Review of Immunology·S GurunathanR A Seder
Oct 25, 2000·Veterinary Immunology and Immunopathology·J M RequenaC Alonso
Dec 13, 2000·International Journal for Parasitology·R W Ashford
Dec 20, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S StägerP M Kaye
Jan 2, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·M BoelaertP Van der Stuyft
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·P C MelbyJ E Coe
Apr 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S MéndezD Sacks
Apr 9, 2001·Clinical Microbiology Reviews·E Handman
Aug 9, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·P Desjeux

❮ Previous
Next ❯

Citations

Mar 27, 2009·Parasitology Research·Virginie WoerlyHyone-Myong Eun
Jan 17, 2014·Journal of Parasitic Diseases : Official Organ of the Indian Society for Parasitology·Tejinder KaurSukhbir Kaur
Jul 23, 2013·International Journal of Pharmaceutics·T T H PhamG Barratt
Sep 30, 2009·Vaccine·Sylvie BertholetSteven G Reed
Oct 24, 2007·Research in Veterinary Science·Rodolfo Cordeiro GiunchettiRicardo Toshio Fujiwara
Aug 24, 2007·The Lancet Infectious Diseases·Richard ReithingerSimon Brooker
Mar 14, 2007·Clinics in Dermatology·Mark S Bailey, Diana N J Lockwood
Apr 25, 2006·Parasite Immunology·J CarriónC Alonso
Nov 1, 2005·Lancet·Henry W MurrayNancy G Saravia
Oct 25, 2007·Expert Opinion on Pharmacotherapy·Mahreen Ameen
Aug 25, 2009·Parasitology International·Camila I de OliveiraManoel Barral-Netto
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Manuel Jesús Chan-BacabBenjamín Otto Ortega-Morales

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.